Generation and characterization of a single-chain fv antibo

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
Generation and characterization of a single-chain fv antibo
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


Related Articles

Generation and characterization of a single-chain fv antibody against gli3, a hedgehog signaling pathway transcription factor.


Hybridoma (Larchmt). 2008 Jun;27(3):167-74


Authors: Laht S, Meerits K, Altroff H, Faust H, Tsaney R, Kogerman P, Järvekülg L, Paalme V, Valkna A, Timmusk S


Abstract Gli3 is a key regulator of development, controlling multiple patterning steps. Here we report the generation of a scFv antibody specific to the repressor domain of human Gli3. We show that this scFv retains the binding capacity of its parent anti-Gli3 monoclonal antibody derived from hybridoma clone 5E1. When expressed in mammalian cells, the anti-Gli3 scFv co-localizes with intracellular Gli3. Immunocytochemical staining of the intrabody in Gli3-positive TM4 cells shows a distinct perinuclear cytoplasmic localization. Such a scFv constitutes a useful tool for studying transcriptional regulation of the hedgehog pathway in mammals and offers a starting point for developing novel Gli-related therapeutic intrabodies.


PMID: 18582209 [PubMed - in process]



Read more...

Source: PubMed: hedgehog
NCBI: db=PubMed; Term=hedgehog
View user's profileSend private message
Generation and characterization of a single-chain fv antibo
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map